7.2 Newborn Physical Examination (NIPE 4 Core Elements) & Routine Prophylaxis

Key Takeaways

  • The Newborn and Infant Physical Examination (NIPE) is an evidence-based UK screening programme conducted within 72 hours of birth and repeated at 6–8 weeks to identify serious congenital abnormalities.

  • The four mandatory NIPE screening elements are: (1) Eyes (examination of the red reflex for cataracts and retinoblastoma), (2) Heart (auscultation, femoral pulses for coarctation, central cyanosis), (3) Hips (Barlow and Ortolani tests for developmental dysplasia), and (4) Testes in males (palpation for cryptorchidism).

  • NIPE hip risk factors are breech at or after 36 weeks, breech at birth from 28 weeks to term, and first-degree family history; screen-positive babies have hip ultrasound, ideally at 4 to 6 weeks.

  • Birth-related cranial trauma must be differentiated with precision: benign caput succedaneum (crosses suture lines, pits), subperiosteal cephalhaematoma (confined by suture lines, hyperbilirubinaemia risk), and life-threatening subgaleal haemorrhage (crosses sutures into neck, massive occult blood loss and shock).

  • A single 1 mg intramuscular dose of vitamin K (phytomenadione) at birth is the most effective prophylaxis against vitamin K deficiency bleeding, including late VKDB.

Last updated: October 2026

Newborn Physical Examination (NIPE 4 Core Elements) & Routine Prophylaxis

The systematic physical examination of the newborn infant represents a cornerstone of preventive neonatal medicine. In the United Kingdom, the Newborn and Infant Physical Examination (NIPE) national screening programme establishes rigorous clinical standards designed to identify major congenital abnormalities early in life. Early detection facilitates timely intervention, preventing lifelong physical disability, intellectual impairment, or premature death. Midwives who undertake post-registration NIPE qualification, along with neonatal nurse practitioners and paediatricians, possess autonomous accountability for conducting the comprehensive 72-hour examination, interpreting clinical findings, initiating urgent referral pathways, and delivering essential pharmacological prophylaxis.


UK National Screening Programme: NIPE Standards & Timing

The UK National Screening Committee (UK NSC) standardises NIPE into a two-phase longitudinal screening pathway:

  1. Initial Newborn Examination: Must be performed within 72 hours of birth (ideally within the first 24 hours prior to discharge from the maternity facility, but once the infant has completed initial physiological transition and is thermally stable).
  2. Infant Follow-up Examination: Performed at 6 to 8 weeks of age, typically by a general practitioner (GP) in primary care, recognising that certain conditions (such as developmental dysplasia of the hip, innocent cardiac murmurs, or undescended testes) evolve dynamically across early infancy.
┌─────────────────────────────────────────────────────────────────────────────────┐
│                     UK NIPE NATIONAL SCREENING TIMELINE                         │
└─────────────────────────────────────────────────────────────────────────────────┘
                                         │
         ┌───────────────────────────────┴───────────────────────────────┐
         ▼                                                               ▼
┌───────────────────────────────────┐           ┌───────────────────────────────────┐
│      EXAMINATION 1: ≤72 HOURS     │           │      EXAMINATION 2: 6–8 WEEKS     │
├───────────────────────────────────┤           ├───────────────────────────────────┤
│• Maternity hospital or home birth │           │• Primary care / GP practice       │
│• Midwife (NIPE qualified) / Doctor│           │• General practitioner / Paediatric│
│• Four core screening elements     │           │• Review of evolving abnormalities │
│• Electronic NIPE SMART logging    │           │• Repeat Barlow/Ortolani, heart    │
│• Safety-netting in 'Red Book'     │           │  auscultation, testes & vision    │
└───────────────────────────────────┘           └───────────────────────────────────┘

Core Assessment Principles

  • Informed Parental Consent: The midwife must provide the national leaflet "Screening tests for you and your baby" during pregnancy and prior to examination, explaining the purpose, benefits, and potential limitations of screening. Explicit verbal consent must be secured and documented.
  • Optimised Examination Environment: The examination should take place in a warm (23–25°C), well-lit room, ensuring optimal thermal protection. The infant should ideally be calm, settled, and examined midway between feeds.
  • Data Governance: Findings are recorded directly on the national electronic system (NIPE SMART) and within the infant's Personal Child Health Record (PCHR / "Red Book").

The Four Core Screening Elements of NIPE

While the NIPE encompasses a holistic, top-to-toe anatomical evaluation, the national screening programme specifically mandates rigorous, auditable surveillance across four core anatomical domains: the Eyes, Heart, Hips, and Testes in male infants.

┌─────────────────────────────────────────────────────────────────────────────────┐
│                        THE 4 CORE NIPE SCREENING DOMAINS                        │
└─────────────────────────────────────────────────────────────────────────────────┘
                                         │
         ┌────────────────┬──────────────┴────────────────┬──────────────┐
         ▼                ▼                               ▼              ▼
┌─────────────────┐┌─────────────────┐             ┌─────────────────┐┌─────────────────┐
│    1. EYES      ││    2. HEART     │             │    3. HIPS      ││   4. TESTES     │
├─────────────────┤├─────────────────┤             ├─────────────────┤├─────────────────┤
│• Red reflex exam││• Auscultate rate│             │• Barlow maneuver││• Scrotal palp-  │
│  (ophthalmoscope││  and murmurs    │             │  (dislocatability)  ation (bilat)│
│• Check symmetry ││• Palpate femoral│             │• Ortolani test  ││• Differentiate  │
│• Detect cataract││  pulses (volume)│             │  (reduction)    ││  retractile vs  │
│  & retinoblast- ││• Check central  │             │• Check risk     ││  cryptorchidism │
│  oma (leukocoria││  cyanosis / CCHD│             │  factors for US ││• CAH check if 2 │
└─────────────────┘└─────────────────┘             └─────────────────┘└─────────────────┘

1. Examination of the Eyes

Visual screening aims to identify structural congenital defects of the globe and ocular media that obstruct the visual axis, potentially leading to irreversible amblyopia (visual pathway deprivation) or indicating life-threatening intraocular malignancy.

  • External Structural Inspection: Inspect the size and symmetry of both eyes (ruling out microphthalmia or anophthalmia), the eyelids (checking for severe ptosis or coloboma), clear conjunctiva without purulent discharge, corneal diameter and clarity (cloudiness suggests congenital glaucoma or intrauterine infection), and pupil shape (keyhole defect indicates iris coloboma, often linked to systemic syndromes such as CHARGE).
  • The Red Reflex Test (Brückner Test):
    • Technique: In a darkened room, the examiner uses a direct ophthalmoscope set to '0' (or adjusted to the examiner's refractive error). The examiner views both eyes simultaneously from a distance of approximately 20 to 30 cm, then examines each eye individually.
    • Normal Finding: A bright, clear, symmetrical, reddish-orange circular reflex reflected back from the vascularised retina through transparent ocular media (cornea, anterior chamber, crystalline lens, and vitreous humor) bilaterally.
    • Abnormal Findings:
      • Leukocoria (White Pupillary Reflex): A white, chalky, or yellowish reflex. This is the cardinal clinical sign of retinoblastoma (a life-threatening malignant intraocular neuroepithelial tumour) or a dense congenital cataract.
      • Absent, Blunted, or Asymmetrical Reflex: Suggests corneal opacification, dense congenital cataract, persistent fetal vasculature, or vitreous haemorrhage.
  • Referral Pathway: Any absence, asymmetry, or white reflex mandates an immediate, urgent referral to a consultant ophthalmologist within 2 weeks (or same-day escalation if retinoblastoma is suspected), as dense cataracts require surgical removal before 6 to 10 weeks of age to prevent permanent cortical visual blindness.

2. Cardiovascular Examination

Cardiovascular screening aims to identify Critical Congenital Heart Disease (CCHD)—defined as structural lesions requiring catheter or surgical intervention within the first 28 days of life (e.g. hypoplastic left heart syndrome, transposition of the great arteries, coarctation of the aorta).

  • General Visual Surveillance: Assess the resting infant for tachypnoea (respiratory rate persistently >60 breaths per minute at rest), increased work of breathing (subcostal/intercostal retractions, sternal indrawing, nasal flaring, expiratory grunting), and abnormal colour (central cyanosis of the tongue, gums, and oral mucous membranes, pallor, or grey/mottled perfusion).
  • Cardiac Auscultation: Auscultate precordial heart sounds, assessing rate (normal 110–160 bpm), rhythm, and distinct first (S1) and second (S2) heart sounds. Listen across all four valve areas (mitral, tricuspid, pulmonary, aortic) and over the infant's back:
    • Heart Murmurs: Innocent systolic murmurs are detected in up to 50% of healthy neonates in the first 48 hours, usually arising from physiological transient flow through a closing ductus arteriosus or peripheral pulmonary branch stenosis.
    • Pathological Indicators: Murmurs that are loud (Grade ≥3/6), harsh, pansystolic, or diastolic; murmurs heard widely across the precordium and back; or ANY murmur accompanied by central cyanosis, tachypnoea, hepatomegaly (>2 cm below right costal margin), or abnormal pulses.
  • Palpation of Femoral Pulses:
    • Technique: Simultaneously palpate the right brachial pulse and both femoral pulses (in the femoral creases midway between the anterior superior iliac spine and pubic symphysis) with warm index fingers.
    • Normal Finding: Femoral pulses are readily palpable, brisk, equal in volume, and synchronized precisely with the brachial pulse.
    • Critical Finding: Weak, thready, delayed, or completely absent femoral pulses relative to brachial pulses. This is the hallmark clinical presentation of Coarctation of the Aorta. As the ductus arteriosus constricts in the first days of life, systemic blood flow to the lower body past the aortic shelf collapses, precipitating metabolic acidosis and cardiogenic shock.
  • Referral Pathway: Any absent/weak femoral pulses or murmur accompanied by clinical compromise warrants immediate same-day transfer to a paediatrician/neonatologist for urgent echocardiography.

3. Orthopaedic Examination: The Hips

Hip screening targets the early identification of Developmental Dysplasia of the Hip (DDH), an umbrella term spanning acetabular dysplasia, joint capsule laxity, subluxation, and complete dislocation of the femoral head from the acetabulum.

  • Visual & Structural Inspection: Place the infant supine on a firm, flat surface. Assess for leg-length discrepancy using the Galeazzi sign: flex both hips and knees to 90 degrees with feet flat on the surface; an apparent difference in knee heights indicates femoral displacement. The NIPE handbook states that skin-crease asymmetry is no longer part of the screen and is not a screen-positive finding; screen-positive signs are leg-length difference, knees at different levels, limited abduction, or a palpable clunk.
  • Dynamic Clinical Provocation Maneuvers:
    • Maneuvers must be performed gently, smoothly, and one hip at a time, while the opposing hand stabilizes the contralateral pelvis.
    • Barlow Maneuver (Testing for Dislocatability): The examiner flexes the infant's hip to 90 degrees and adducts the thigh toward the midline while exerting gentle posterior pressure along the femoral shaft. A positive test is characterized by a palpable sensation of the femoral head slipping or dislocating out of the acetabulum over the posterior rim (the clunk of exit).
    • Ortolani Maneuver (Testing for Reducibility of a Dislocated Hip): Starting from an adducted, flexed position, the examiner gently abducts the hip outward toward the examination bed while applying anterior lifting pressure with the fingers behind the greater trochanter. A positive test is confirmed by a distinct, palpable "clunk" as the displaced femoral head is lifted and relocates cleanly into the acetabular cup (the clunk of entry).
    • Clicks vs Clunks: High-pitched, soft "clicks" are common and represent benign movement of ligaments or fascia; they do not indicate DDH. True joint instability manifests as a dull, distinct, palpable clunk.

Important

Targeted Hip Ultrasound Screening Pathways (Within 6 Weeks): Even if the clinical Barlow and Ortolani tests are entirely normal, UK NIPE standards mandate a hip ultrasound scan, ideally at 4 to 6 weeks of age, for infants with defined major risk factors:

  1. Breech presentation at or after 36 completed weeks of pregnancy (irrespective of whether the infant was born vaginally or by caesarean section, and regardless of whether cephalic presentation was achieved before birth via successful External Cephalic Version [ECV]).
  2. Breech presentation at the time of birth between 28 weeks' gestation and term.
  3. First-degree family history of DDH (mother, father, brother, or sister diagnosed with or treated for DDH in infancy with a Pavlik harness, splint, or surgery).
  4. Multiple pregnancy: all babies from a multiple pregnancy have a hip ultrasound if any NIPE hip risk factor is present, or if any of the babies is screen positive on examination. Clinical Abnormality: A baby with an abnormal clinical hip examination (with or without risk factors) is also screen positive. The NIPE handbook recommends hip ultrasound ideally between 4 and 6 weeks of age, so that an outcome decision is made and any treatment starts by 6 weeks (for babies born before 34+0 weeks, the scan is at 38+0 to 40+0 weeks corrected age).

4. Examination of the Genitalia (Testes in Males)

Genital screening in male infants focuses on identifying cryptorchidism (undescended testes), which affects about 2% to 6% of term male infants (NIPE handbook).

  • Anatomical Inspection: Inspect the penis, verifying that the urethral meatus opens symmetrically at the tip of the glans. Identify hypospadias (abnormal ventral opening on the underside of the shaft) or epispadias (abnormal dorsal opening). In hypospadias, the prepuce is characteristically hooded; circumcision is contraindicated because the foreskin is preserved for future surgical reconstruction.
  • Palpation of the Testes:
    • Technique: Place warm fingers across the inguinal canal to prevent the active cremasteric reflex from retracting the testis. Gently milk the contents of the inguinal canal downwards into the scrotal sac, palpating between index finger and thumb.
    • Differentiating Retractile Testis vs Cryptorchidism: A retractile testis can be manipulated fully to the base of the scrotum and remains in position without tension until a cremasteric stimulus causes retraction. An undescended testis cannot be brought into the scrotum, or snaps back immediately upon release.
  • Referral Pathways & Clinical Urgency:
    • Urgent Review within 24 Hours: Bilateral impalpable testes, a unilateral impalpable testis (with or without hypospadias), a unilateral palpable undescended testis with hypospadias, or a disorder of sex development requires review by a consultant paediatrician or associate specialist within 24 hours. Bilateral absence of palpable gonads in an apparent male neonate warrants urgent investigation to exclude Congenital Adrenal Hyperplasia (CAH) (a life-threatening endocrine disorder presenting with severe salt-wasting adrenal crisis, hyponatraemia, and hyperkalaemia within the first weeks of life) and disorders of sex development (DSD).
    • Palpable Undescended Testis without Hypospadias: Non-urgent; it is reviewed at the 6 to 8-week NIPE infant examination. Any testis that is palpable but not in the scrotum should have a GP review at 4 to 5 months, with referral to a surgeon (to be seen by 6 months) if still undescended, for orchidopexy (usually between 6 and 12 months of age) to preserve spermatogenesis and facilitate future self-examination for testicular malignancy.

General Physical Examination & Cranial Birth Trauma

Beyond the four core screening domains, the NIPE incorporates a comprehensive top-to-toe clinical appraisal.

Cranial Architecture & Fontanelles

  • Head Circumference (Occipitofrontal Circumference / OFC): Measured across the widest diameter (supraorbital ridges to the most prominent part of the occiput) using a non-stretchable tape, plotted on UK-WHO growth charts.
  • Fontanelles & Sutures: Palpate the anterior fontanelle (diamond-shaped, 2–4 cm, soft and flat; normally closes between 12 and 18 months) and the posterior fontanelle (triangular, <1 cm; closes by 6 to 8 weeks). A bulging, tense fontanelle indicates raised intracranial pressure (meningitis, hydrocephalus); a depressed fontanelle signals severe dehydration. Sutures may override slightly due to physiological moulding during labour.

Differential Diagnosis of Cranial Birth Trauma

Mechanical forces during labour and instrumental delivery (ventouse/vacuum extraction or forceps) can cause distinct cranial swellings. Midwives must differentiate them accurately:

Clinical CharacteristicCaput SuccedaneumCephalhaematomaSubgaleal Haemorrhage
Anatomical Tissue LayerSubcutaneous tissue above the epicranial aponeurosis.Subperiosteal space between skull bone and periosteum.Loose subaponeurotic space beneath epicranial aponeurosis.
Crosses Suture Lines?YES, crosses cranial suture lines freely.NO, strictly confined by suture line periosteal margins.YES, crosses suture lines; extends into neck and periorbital spaces.
Onset & PalpationPresent at birth; soft, boggy, pitting oedema.Appears hours/days after birth; firm, tense, non-pitting rim.Appears hours after birth; progressive, fluctuant, fluid wave.
Resolution TimelineResolves rapidly within 24 to 72 hours.Resolves slowly over 2 to 8 weeks (may calcify).Requires intensive paediatric emergency management.
Clinical Risks & SeverityBenign; requires zero intervention.Increased risk of neonatal jaundice (RBC breakdown).Life-threatening emergency; massive occult blood loss, shock, DIC.
┌─────────────────────────────────────────────────────────────────────────────────┐
│                     ANATOMY OF CRANIAL BIRTH SWELLINGS                          │
└─────────────────────────────────────────────────────────────────────────────────┘
 Skin & Subcutis ───────────────────────────────────┐
 Galea Aponeurotica ─────────────────────────────┐   │ Caput Succedaneum
 Subgaleal Space (Subgaleal Haemorrhage) ─────┐   │   │ (Crosses suture lines)
 Periosteum ───────────────────────────────┐   │   │   │
 Subperiosteal Space (Cephalhaematoma) ──┐ │   │   │   │
 Cranial Bone ─────────────────────────┐ │ │   │   │   │
 Suture Line ───────────────► │ ◄──────┴─┴─┴───┴───┴───┘
                                (Cephalhaematoma cannot cross suture)

Systematic Oral Cavity & Palate Inspection

The oral cavity must be examined systematically using a direct light source (torch) and visual inspection, supplemented by digital palpation:

  • Visual Inspection: Depress the tongue to visualize the uvula and the entire length of the hard and soft palates.
  • Digital Palpation: The midwife inserts a gloved index or little finger, palpating the contour of the hard palate and sweeping across the junction of the soft palate.
  • Clinical Rationale: Visual inspection alone frequently fails to detect isolated cleft palate (clefting of the secondary palate without cleft lip), which is concealed behind intact alveolar ridges. Missed cleft palate leads to immediate feeding difficulties, nasal regurgitation, failure to thrive, and recurrent aspiration pneumonia.

Routine Neonatal Prophylaxis: Vitamin K (Phytomenadione)

Newborn infants are born with a physiological deficiency of vitamin K, predisposing them to spontaneous, life-threatening haemorrhage known as Vitamin K Deficiency Bleeding (VKDB) (historically termed haemorrhagic disease of the newborn).

Pathophysiological Rationale

Vitamin K acts as an indispensable cofactor for hepatic gamma-glutamyl carboxylase, which carboxylates glutamic acid residues on coagulation factors II (prothrombin), VII, IX, and X, as well as natural regulatory proteins C and S. Without adequate vitamin K, these clotting factors remain inactive (known as PIVKA: Proteins Induced by Vitamin K Absence).

Neonates are vulnerable because:

  1. Minimal Transplacental Transfer: Vitamin K transfers poorly across the placental barrier; cord blood concentrations are negligible.
  2. Hepatic Immaturity: Neonatal hepatic storage capacity is low.
  3. Sterile Neonatal Gut: The fetal and early neonatal intestine contains no bacterial flora (such as Bacteroides and E. coli) capable of synthesizing menaquinone (vitamin K2).
  4. Low Concentrations in Breast Milk: Mature human breast milk contains extremely low concentrations of vitamin K (approximately 1 to 4 mcg/L), whereas fortified infant formula contains >50 mcg/L.

Clinical Classification of VKDB

VKDB TypeOnset WindowCommon Clinical PresentationsAssociated Risk Factors & Characteristics
Early VKDBFirst 24 hours of life.Severe cephalhaematoma, intracranial haemorrhage, intra-abdominal bleeding.Maternal enzyme-inducing drugs that cross placenta (carbamazepine, phenytoin, phenobarbital, warfarin, rifampicin, isoniazid).
Classical VKDBDay 2 to Day 7 of life.Bleeding from umbilical stump, gastrointestinal tract (melaena, haematemesis), purpura, oozing from skin punctures.Delayed feeding, poor feeding establishment, failure to administer routine prophylaxis at birth.
Late VKDB2 to 12 weeks of age (up to 6 months).Intracranial haemorrhage (50% to 70% of cases), sudden collapse, bulging fontanelle, seizures, deep jaundice.Almost exclusively in exclusively breastfed infants who did not receive prophylaxis; high mortality (20%) and permanent brain damage.

Administration Protocols & Comparative Efficacy

Midwives must discuss vitamin K prophylaxis antenatally and obtain informed consent immediately following birth.

  • Intramuscular (IM) Phytomenadione (Gold Standard):
    • Regimen: A single dose of 1.0 mg phytomenadione (0.1 mL) administered via deep intramuscular injection into the vastus lateralis (anterolateral aspect of the middle third of the thigh) shortly after birth.
    • Efficacy: Provides 100% bioavailability, establishes a reliable hepatic depot, and is the most effective way to prevent VKDB, particularly late VKDB, which becomes very rare after IM prophylaxis. It is the recommended regimen across UK maternity units.
  • Oral Phytomenadione Regimen (Alternative for Parental Refusal):
    • Regimen: For parents who refuse the intramuscular injection, a multi-dose oral regimen is prescribed, requiring three 2.0 mg doses:
      1. Dose 1: 2.0 mg orally at birth with the first feed.
      2. Dose 2: 2.0 mg orally between day 4 and day 7.
      3. Dose 3: 2.0 mg orally at 4 weeks of age (strictly mandatory for exclusively breastfed infants; formula-fed infants who have received two doses and take ≥500 mL/day of formula do not strictly require the third dose, but completing the course is safest practice).
    • Clinical Limitations: Oral prophylaxis relies on strict parental compliance over several weeks; oral bioavailability is unpredictable; infants may regurgitate or vomit the dose; and oral regimens provide significantly inferior protection against late VKDB, especially in the presence of occult neonatal cholestatic liver disease (e.g. biliary atresia).

Warning

If parents decline both intramuscular and oral vitamin K prophylaxis, the midwife must record a detailed, signed refusal in the infant's records, provide written safety-netting information, and educate the parents to report any early warning signs of VKDB immediately: spontaneous bruising, bleeding from the umbilical cord stump, persistent oozing from heel-pricks, black tarry stools, or pale lethargic appearance.

Loading diagram...
NIPE Four Core Screening Elements & Targeted Clinical Pathways
Test Your Knowledge

A midwife is performing the 72-hour NIPE examination on a term infant born by elective caesarean section for persistent breech presentation diagnosed at 37 weeks' gestation. The clinical Barlow and Ortolani tests are completely normal. What is the required clinical management pathway under UK NIPE standards?

A

Reassure the parents that normal clinical tests confirm healthy hips and discharge the infant to routine 6–8 week GP surveillance without further imaging

B

Perform an immediate plain pelvic X-ray before hospital discharge to confirm femoral head ossification

C

Arrange an emergency orthopaedic review within 48 hours for immediate application of a Pavlik harness

D

Book a targeted screening ultrasound scan of both hips to be performed within 6 weeks of birth

Test Your Knowledge

Twelve hours after a vacuum-assisted delivery, a neonate is examined. The midwife notes a firm, circumscribed cranial swelling over the right parietal bone that does NOT cross the sagittal or coronal suture lines. The infant is alert and hemodynamically stable. What is the diagnosis and primary clinical consideration?

A

Cephalhaematoma; manage expectantly as it resolves over weeks, but monitor closely for neonatal hyperbilirubinaemia due to red blood cell breakdown

B

Caput succedaneum; apply gentle pressure dressings to accelerate resorption of subcutaneous oedema within 24 hours

C

Subgaleal haemorrhage; immediately crossmatch blood and prepare for emergency neurosurgical drainage to prevent fatal shock

D

Depressed skull fracture; obtain an urgent computed tomography (CT) scan and restrict handling

Test Your Knowledge

Parents of an exclusively breastfed healthy newborn decline the intramuscular vitamin K injection but agree to the oral regimen. What specific dosing schedule must the midwife prescribe, and what critical risk must be explained?

A

A single 2.0 mg oral dose at birth; oral dosing confers identical 100% long-term protection against late VKDB as the intramuscular injection

B

Two 1.0 mg oral doses at birth and day 28; breast milk provides sufficient vitamin K to prevent late VKDB without further doses

C

Three 2.0 mg oral doses (at birth, at 4–7 days, and at 4 weeks); the oral route provides inferior protection against late VKDB, which carries a high risk of intracranial haemorrhage

D

Weekly 0.5 mg oral drops for the first 12 weeks of life; oral vitamin K is contraindicated if the infant regurgitates any feeds

Sections you finish are checked off in the contents.